Recent Updates
Recently added Catalysts
WST Positive Sentiment Score: 75/100

West to Participate in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...

Key Takeaway: West Pharmaceutical Services, Inc. will present at the Bank of America Global Healthcare Conference on September 18, 2024, in London, UK. The presentation will be accessible through a live audio webcast on the company's website, promoting transparency. For fiscal year 2023, West reported $2.95 billion in net sales, demonstrating its significant role in the healthcare sector. With a global workforce and extensive product offerings, West continues to support drug developers effectively.

Market Sentiment Analysis

POSITIVE FACTORS

  • West Pharmaceutical Services is participating in a significant investor conference.
  • The company demonstrates transparency with a live audio webcast of its presentation.
  • West has a strong track record with $2.95 billion in net sales for fiscal year 2023.
  • The company supports drug developers globally with high-quality injectable solutions.

Full Press Release Details

EXTON, Pa. , Sept. 5, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Global Healthcare Conference in London, UK on Wednesday, September 18, 2024 , at 9:55 AM BST .
A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com . Replay of the webcasts will be available for approximately 90 days after the events.
About West West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in Exton, Pennsylvania , West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com .
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
SOURCE West Pharmaceutical Services, Inc.

21 %

Frequently Asked Questions

When will West Pharmaceutical present at the conference?

West Pharmaceutical will present on September 18, 2024, at 9:55 AM BST.

Where can I watch the West Pharmaceutical webcast?

The live webcast is available in the 'Investors' section of their website.

How long will the webcast replay be available?

The replay of the webcasts will be accessible for about 90 days.

What does West Pharmaceutical specialize in?

West specializes in innovative injectable solutions and services.

What were West's net sales in fiscal year 2023?

In fiscal year 2023, West generated $2.95 billion in net sales.

Last updated: Sep 5, 2024